Die aktuelle Ausgabe (1/2019) der Mitteilungen der Anatomischen Gesellschaft können hier eingesehen oder heruntergeladen werden.
News
Paper of the Month 2019-05
Veröffentlicht am 4. Jul 2019
Im Paper of the Month für den Mai schreiben Jan Philipp Schneider und Kollegen von der Medizinischen Hochschule Hannover "Über die topologische Komplexität humaner Alveolarepithelzellen vom Typ 1".
[Stellenmarkt] Neues Stellenangebot
Veröffentlicht am 3. Jul 2019
Das Institut für Anatomie I der Heinrich-Heine-Universität Düsseldorf sucht zum nächstmöglichen Zeitpunkt eine Präparationstechnische Assistentin/einen Präparationstechnischen Assistenten (m/w/d). Die Stelle ist befristet für die Abwesenheit der Stelleninhaberin/des Stelleninhabers, mindestens jedoch für 1 Jahr. Details.
Paper of the Month 2019-04
Veröffentlicht am 2. Jul 2019
Das Paper of the Month für den April kommt von Athanassios Fragoulis und Kollegen. Sie schreiben zu dem Thema "Nrf2 mildert die DDC-induzierte Cholangitis & Fibrose und verbessert das Regenerationspotential der Leber."
The upcoming AG annual meeting 2019: keynote speakers
Veröffentlicht am 1. Jul 2019
As part of the upcoming AG annual meeting, we are happy to announce the following keynote speakers:
25.09.2019, 15:00
"Spatiotemporal dynamics of T cell activation"
Prof. Wolfgang Kastenmüller
Director, Institute of Virology and Immunobiology
Institute for System Immunology I
Max-Planck-Research Group
Würzburg / Germany
Wolfgang Kastenmüller, MD Clinical Fellow/Post-Doc, Technical University of Munich until 2008, postdoctoral fellow, NIH/Bethesda USA until 2012, Associate Professor at University of Bonn / Germany until 2017 und since 2017 full Professor, Director of Immunobiology and leader Max-Planck Group “Systems Immunology”, Würzburg, Germany.
His lab focuses on cell-cell communication and interactions in the context of infectious diseases with a specific interest in the interface between innate and adaptive immunity. Using intravital microscopy his lab has identified the spatiotemporal dynamics of lymphocyte activation in the context of viral infections. In particular, his team has uncovered how CD4+ T cell help for cytotoxic lymphocytes is orchestrated. Wolfgang Kastenmüller’s awards include the Dietma-Zumpf-Promotions Preis, the Awardee NRW-Rückkehr Programm, CIG-Best Paper Award NIH, DFG Fellowship and ERC Consolidator Grant 2018.
25.09.2019, 16:00
“Unbiased 3D histology of intact specimen using tissue transparency and deep learning”
Dr. Ali Ertürk
Institute of Stroke and Dementia Research (ISD)
Klinikum der Universität München
Ludwig Maximilians University of Munich
From 2003 to 2008 Dr. Ali Ertürk did his Ph.D study at the Max–Planck–Institute of Neurobiology as a student of the Ludwig-Maximilians-Universität (LMU), Munich, Germany; he was a Postdoctoral fellow at the Max–Planck–Institute of Neurobiology (2008 - 2009 ) and 2009 – 2014 at Genentech, South San Francisco. Since July 2014 he is an Independent Junior Group Leader at the Institute for Stroke and Dementia (ISD) – LMU Munich, Germany
His lab focuses on the genetics, the cellular mechanisms including the immune system involved in system stroke to identify molecular targets and to develop novel therapeutic approaches.
Ali Ertürk was awarded an Early Stage Researcher (ESR) Fellowship from the Marie Curie program of the EU as a member of “Nervous System Repair” research training network, a postdoctoral program within the Neuroscience department at Genentech, and also received an ERA-Net grant
26.09.2019, 10:30
"From haploid stem cells to blood vessel engineering"
Prof. Josef Penninger
Prof. Josef Penninger
Director, Life Sciences Institute, UBC
Professor, Department of Medical Genetics, UBC
Professor of Genetics, University of Vienna
Guest Professor, Medical University of Vienna
Adjunct Professor, Department of Immunology, University of Toronto
Prof. Josef Penninger, MD was formerly a lead researcher at the Amgen Research Institute in Toronto. Since 2002 Josef Penninger has been the Founding and Scientific Director of the newly established Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna, Austria. In 2018 he accepted the appointment as Director of the Life Sciences Institute (LSI) at the University of British Columbia (UBC) in Canada.
Major achievements include pioneering insights into the molecular basis of osteoporosis and breast cancer, as well as the study of metastatic spread. Josef Penninger’s major awards include the Descartes Prize, the Wittgenstein Prize of the Austrian Federal Government, the Ernst Jung Prize for medical excellence, an AAAS Award, the Innovator Award from Era of Hope/U.S. Department of Defense and a second ERC Advanced grant.
